Stoke Therapeutics Inc’s recently made public that its CHIEF MEDICAL OFFICER Ticho Barry unloaded Company’s shares for reported $33596.0 on Dec 09 ’24. In the deal valued at $12.99 per share,2,586 shares were sold. As a result of this transaction, Ticho Barry now holds 44,746 shares worth roughly $0.52 million.
Then, Allan Jonathan sold 13,666 shares, generating $185,978 in total proceeds. Upon selling the shares at $13.61, the GENERAL COUNSEL & CORP SEC now owns 21,476 shares.
Before that, Kaye Edward M. MD sold 6,786 shares. Stoke Therapeutics Inc shares valued at $88,158 were divested by the CEO at a price of $12.99 per share. As a result of the transaction, Kaye Edward M. MD now holds 61,885 shares, worth roughly $0.72 million.
Chardan Capital Markets initiated its Stoke Therapeutics Inc [STOK] rating to a Buy in a research note published on December 20, 2024; the price target was $24. TD Cowen also remained covering STOK and has increased its forecast on March 26, 2024 with a “an Outperform” recommendation from previously “Market perform” rating.
Price Performance Review of STOK
On Friday, Stoke Therapeutics Inc [NASDAQ:STOK] saw its stock jump 3.36% to $11.68. Over the last five days, the stock has lost -3.15%. Stoke Therapeutics Inc shares have risen nearly 122.05% since the year began. Nevertheless, the stocks have risen 140.08% over the past one year. While a 52-week high of $17.58 was reached on 06/13/24, a 52-week low of $4.09 was recorded on 02/13/24. SMA at 50 days reached $12.48, while 200 days put it at $12.96.
Levels Of Support And Resistance For STOK Stock
The 24-hour chart illustrates a support level at 11.05, which if violated will result in even more drops to 10.41. On the upside, there is a resistance level at 12.08. A further resistance level may holdings at 12.47. The Relative Strength Index (RSI) on the 14-day chart is 44.25, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.99, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 71.66%. Stochastics %K at 18.34% indicates the stock is a buying.
How much short interest is there in Stoke Therapeutics Inc?
A steep rise in short interest was recorded in Stoke Therapeutics Inc stocks on 2024-11-29, growing by 33713.0 shares to a total of 6.73 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 6.7 million shares. There was a rise of 0.5%, which implies that there is a positive sentiment for the stock.
